Similar articles

• Dementia update. Pharmacologic management of agitation and psychosis in older demented patients.

  Zaraa AS. Zaraa AS. Geriatrics. 2003 Oct;58(10):48-50, 52-3. Geriatrics. 2003. PMID: 14569642 Review. No abstract available.
• Sedation--therapeutic or side effect in psychoses. Introduction.

  Miller DD. Miller DD. Pharmacotherapy. 1996 Nov-Dec;16(6 Pt 2):141S-142S. Pharmacotherapy. 1996. PMID: 8947996 No abstract available.
• Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?

  Oechsner M, Korchounov A. Oechsner M, et al. Hum Psychopharmacol. 2005 Apr;20(3):203-5. doi: 10.1002/hup.682. Hum Psychopharmacol. 2005. PMID: 15799011 Clinical Trial.
• Pharmacologic interventions for psychosis and agitation in neurodegenerative diseases: evidence about efficacy and safety.

  Weintraub D, Katz IR. Weintraub D, et al. Psychiatr Clin North Am. 2005 Dec;28(4):941-83, ix-x. doi: 10.1016/j.psc.2005.09.002. Psychiatr Clin North Am. 2005. PMID: 16325736 Review. No abstract available.
• [Withdrawal of delayed-action neuroleptics in psychotic patients].

  Maillard M, Coutanceau R, Marchina JC. Maillard M, et al. Ann Med Psychol (Paris). 1979 Mar-Apr;137(3-4):351-5. Ann Med Psychol (Paris). 1979. PMID: 40514 French. No abstract available.